Psyllid ID: psy5192

Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320----
METQNLKGYKSDETVSITEKYLGIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPNFMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAILNPLSARPSKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPAGRIHLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGNAQDSRDATLMKNKKKVIKMLVIVVALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKERKKN
ccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHcHHHEHHHccccccccHHHHHHHHHHHHHHHHHHHcccHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHccHHHHHHHHccccccccc
ccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHEHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccHHHHHHHHcccccccHHHcHHHHHHHHHHHHHHHHHHHHHHHHEEEEEccccccccHHHHHHHHHHHHHHHHHHHccccEEEEEEcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHcccccHHHHHHHHHHHHHHHccccHHHHHEHcHHHcccc
metqnlkgyksdetvSITEKYLGIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQrwnlpnfmcpfcpfvqcLTVTVSVLTLTAIAVDRHRAILnplsarpskLRAKICIFGIWtlssflaapmaiatgvtmeeeytdpagrihlkpfctnihlsddTMILYRRVLAVVQYAIPLSVISFVYARMALRLwgskapgnaqdsrDATLMKNKKKVIKMLVIVVALFAICWLPLQTYNVLqgifpsinsyhYINIVFFCCDWlamsnscynpfiygiyndkerkkn
metqnlkgyksdetvSITEKYLGIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPNFMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAIlnplsarpsklRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPAGRIHLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWGskapgnaqdsrDATLMKNKKKVIKMLVIVVALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIygiyndkerkkn
METQNLKGYKSDETVSITEKYLGIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPNFMCPFCPFVQCltvtvsvltltAIAVDRHRAILNPLSARPSKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPAGRIHLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGNAQDSRDATlmknkkkvikmlvivvALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKERKKN
*************TVSITEKYLGIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPNFMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAILNPLSARPSKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPAGRIHLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWGS****************NKKKVIKMLVIVVALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYN*******
************ETVSITEKYLGIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPNFMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAILNPLSARPSKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPAGRIHLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRL************************IKMLVIVVALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIY*DKER***
**********SDETVSITEKYLGIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPNFMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAILNPLSARPSKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPAGRIHLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGNAQDSRDATLMKNKKKVIKMLVIVVALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKERKKN
***************SITEKYLGIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPNFMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAILNPLSARPSKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPAGRIHLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWGSK**************KNKKKVIKMLVIVVALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKER***
ooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiii
oooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiii
oooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiii
oooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiii
ooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiii
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
METQNLKGYKSDETVSITEKYLGIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPNFMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAILNPLSARPSKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPAGRIHLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGNAQDSRDATLMKNKKKVIKMLVIVVALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKERKKN
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

Original result of BLAST against SWISS-PROT Database

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query324 2.2.26 [Sep-21-2011]
P30975 519 Tachykinin-like peptides no N/A 0.907 0.566 0.347 1e-44
P25931464 Neuropeptide Y receptor O no N/A 0.876 0.612 0.351 2e-43
O02835383 Neuropeptide Y receptor t yes N/A 0.910 0.770 0.34 8e-41
P21452398 Substance-K receptor OS=H yes N/A 0.919 0.748 0.328 1e-40
Q9WVD0383 Neuropeptide Y receptor t yes N/A 0.910 0.770 0.336 1e-40
P30974 504 Tachykinin-like peptides no N/A 0.913 0.587 0.319 2e-40
P21555382 Neuropeptide Y receptor t yes N/A 0.910 0.772 0.336 3e-40
Q04573382 Neuropeptide Y receptor t yes N/A 0.910 0.772 0.336 4e-40
O02813382 Neuropeptide Y receptor t yes N/A 0.910 0.772 0.33 1e-39
P25929384 Neuropeptide Y receptor t no N/A 0.910 0.768 0.333 3e-39
>sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster GN=Takr99D PE=2 SV=2 Back     alignment and function desciption
 Score =  180 bits (456), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 166/299 (55%), Gaps = 5/299 (1%)

Query: 25  YKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLF 84
           + VP    +L S+ +G + ++A  GN +V+WIV T++RM+ VTN FI NL++AD ++   
Sbjct: 94  FVVPWWRQVLWSILFGGMVIVATGGNLIVVWIVMTTKRMRTVTNYFIVNLSIADAMVSSL 153

Query: 85  AIPFQFQAALLQRWNLPNFMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAILNPLSARPSK 144
            + F +   L   W    F C    F+  L++  SV TL AI++DR+ AI+ PL  R SK
Sbjct: 154 NVTFNYYYMLDSDWPFGEFYCKLSQFIAMLSICASVFTLMAISIDRYVAIIRPLQPRMSK 213

Query: 145 LRAKICIFG-IWTLSSFLAAPMAIATGVTMEEEYTDPAGRIHLKPFCTNIHLSDDTM-IL 202
            R  + I   IW  S+ ++ PM I    T E      + R    P   +   +  TM  L
Sbjct: 214 -RCNLAIAAVIWLASTLISCPMMIIYR-TEEVPVRGLSNRTVCYPEWPDGPTNHSTMESL 271

Query: 203 YRRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGNAQDSRDATLMKNKKKVIKMLVIVV 262
           Y  ++ ++ Y +P+  ++  Y+R+ + LWGSK  G     R    +++K++V+KM+++VV
Sbjct: 272 YNILIIILTYFLPIVSMTVTYSRVGIELWGSKTIGECTP-RQVENVRSKRRVVKMMIVVV 330

Query: 263 ALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKER 321
            +FAICWLP  +Y ++   +P+I    +I  ++    WLAMSNS YNP IY   N + R
Sbjct: 331 LIFAICWLPFHSYFIITSCYPAITEAPFIQELYLAIYWLAMSNSMYNPIIYCWMNSRFR 389
Probable receptor for tachykinin-like peptides.
Drosophila melanogaster (taxid: 7227)
>sp|P25931|NPYR_DROME Neuropeptide Y receptor OS=Drosophila melanogaster GN=NepYr PE=2 SV=2 Back     alignment and function description
>sp|O02835|NPY1R_PIG Neuropeptide Y receptor type 1 OS=Sus scrofa GN=NPY1R PE=2 SV=2 Back     alignment and function description
>sp|P21452|NK2R_HUMAN Substance-K receptor OS=Homo sapiens GN=TACR2 PE=2 SV=3 Back     alignment and function description
>sp|Q9WVD0|NPY1R_CAVPO Neuropeptide Y receptor type 1 OS=Cavia porcellus GN=NPY1R PE=3 SV=1 Back     alignment and function description
>sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster GN=Takr86C PE=2 SV=2 Back     alignment and function description
>sp|P21555|NPY1R_RAT Neuropeptide Y receptor type 1 OS=Rattus norvegicus GN=Npy1r PE=2 SV=3 Back     alignment and function description
>sp|Q04573|NPY1R_MOUSE Neuropeptide Y receptor type 1 OS=Mus musculus GN=Npy1r PE=2 SV=1 Back     alignment and function description
>sp|O02813|NPY1R_CANFA Neuropeptide Y receptor type 1 OS=Canis familiaris GN=NPY1R PE=2 SV=2 Back     alignment and function description
>sp|P25929|NPY1R_HUMAN Neuropeptide Y receptor type 1 OS=Homo sapiens GN=NPY1R PE=2 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

Original result of BLAST against Nonredundant Database

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query324
328712195 440 PREDICTED: neuromedin-K receptor-like [A 0.938 0.690 0.712 1e-122
380022778 454 PREDICTED: tachykinin-like peptides rece 0.947 0.676 0.695 1e-120
328787483 487 PREDICTED: leucokinin receptor [Apis mel 0.950 0.632 0.688 1e-119
340723095 465 PREDICTED: neuropeptide Y receptor-like 0.947 0.660 0.698 1e-118
340723093 456 PREDICTED: neuropeptide Y receptor-like 0.947 0.673 0.698 1e-118
197209914 483 neuropeptide receptor A23 [Bombyx mori] 0.947 0.635 0.669 1e-118
350414041 456 PREDICTED: neuropeptide Y receptor-like 0.947 0.673 0.691 1e-117
357616657 488 neuropeptide receptor A23 [Danaus plexip 0.990 0.657 0.629 1e-114
383850279423 PREDICTED: neuropeptide Y receptor-like 0.910 0.697 0.674 1e-112
50910928 573 myokinin receptor [Anopheles stephensi] 0.947 0.535 0.628 1e-112
>gi|328712195|ref|XP_001944708.2| PREDICTED: neuromedin-K receptor-like [Acyrthosiphon pisum] Back     alignment and taxonomy information
 Score =  442 bits (1137), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 223/313 (71%), Positives = 252/313 (80%), Gaps = 9/313 (2%)

Query: 18  TEKYLG---IYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANL 74
           TE YL    +Y VP SII+LLS+FYGTISV+AVVGN LVIWIV +SRRM NVTN +IANL
Sbjct: 40  TEFYLEPTLLYDVPVSIILLLSMFYGTISVMAVVGNALVIWIVTSSRRMHNVTNLYIANL 99

Query: 75  ALADIVIGLFAIPFQFQAALLQRWNLPNFMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAI 134
           ALADIVIGLF+IPFQFQAALLQRWNLP  MCPFCPFVQ L+V VS+ TLTAIAVDRHRAI
Sbjct: 100 ALADIVIGLFSIPFQFQAALLQRWNLPALMCPFCPFVQVLSVNVSIFTLTAIAVDRHRAI 159

Query: 135 LNPLSARPSKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPAGRIH----LKPFC 190
           L+PLSA PSK RAK+ I  IW ++  LA PMAIA  V    EY D  G  +    +KPFC
Sbjct: 160 LSPLSAIPSKFRAKMSIAAIWVIAFALATPMAIALRVQF-IEYGD-RGETYFIFLVKPFC 217

Query: 191 TNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGNAQDSRDATLMKN 250
            N+ L + TM+ YR  L  VQY +P+ +I+ VY RMALRLWGS APGNAQDSRDA LM+N
Sbjct: 218 YNVRLPERTMLFYRLTLLFVQYLVPVVIITVVYMRMALRLWGSHAPGNAQDSRDANLMRN 277

Query: 251 KKKVIKMLVIVVALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNP 310
           KKKVIKMLVIVV LF +CWLPLQTYNVLQ IFPSIN + YINIVFFCCDWLAMSNSCYNP
Sbjct: 278 KKKVIKMLVIVVGLFVLCWLPLQTYNVLQDIFPSINQFRYINIVFFCCDWLAMSNSCYNP 337

Query: 311 FIYGIYNDKERKK 323
           FIYGIYN+K +++
Sbjct: 338 FIYGIYNEKFKRE 350

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota
>gi|380022778|ref|XP_003695214.1| PREDICTED: tachykinin-like peptides receptor 99D-like [Apis florea] Back     alignment and taxonomy information
>gi|328787483|ref|XP_396025.3| PREDICTED: leucokinin receptor [Apis mellifera] Back     alignment and taxonomy information
>gi|340723095|ref|XP_003399933.1| PREDICTED: neuropeptide Y receptor-like isoform 2 [Bombus terrestris] Back     alignment and taxonomy information
>gi|340723093|ref|XP_003399932.1| PREDICTED: neuropeptide Y receptor-like isoform 1 [Bombus terrestris] Back     alignment and taxonomy information
>gi|197209914|ref|NP_001127721.1| neuropeptide receptor A23 [Bombyx mori] gi|195947016|dbj|BAG68422.1| neuropeptide receptor A23 [Bombyx mori] Back     alignment and taxonomy information
>gi|350414041|ref|XP_003490188.1| PREDICTED: neuropeptide Y receptor-like [Bombus impatiens] Back     alignment and taxonomy information
>gi|357616657|gb|EHJ70314.1| neuropeptide receptor A23 [Danaus plexippus] Back     alignment and taxonomy information
>gi|383850279|ref|XP_003700723.1| PREDICTED: neuropeptide Y receptor-like [Megachile rotundata] Back     alignment and taxonomy information
>gi|50910928|gb|AAT88068.1| myokinin receptor [Anopheles stephensi] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

Original result of BLAST against Gene Ontology (AMIGO)

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query324
FB|FBgn0035610 542 Lkr "Leucokinin receptor" [Dro 0.925 0.553 0.559 1.5e-90
WB|WBGene00006428395 tkr-3 [Caenorhabditis elegans 0.898 0.736 0.32 3.2e-42
FB|FBgn0004622 519 Takr99D "Tachykinin-like recep 0.907 0.566 0.311 2.4e-37
UNIPROTKB|Q8QFM1385 NPY1R "Uncharacterized protein 0.882 0.742 0.309 2.1e-36
FB|FBgn0004842464 NepYr "Neuropeptide Y receptor 0.873 0.609 0.315 5.7e-36
UNIPROTKB|Q8QGM3377 PPYR1 "Uncharacterized protein 0.898 0.771 0.294 5.7e-36
UNIPROTKB|O02835383 NPY1R "Neuropeptide Y receptor 0.888 0.751 0.317 1.2e-35
ZFIN|ZDB-GENE-060526-185413 tacr1a "tachykinin receptor 1a 0.910 0.714 0.324 1.2e-35
UNIPROTKB|F1NJ82419 TACR3 "Uncharacterized protein 0.873 0.675 0.322 1.9e-35
ZFIN|ZDB-GENE-980526-393377 npy4r "neuropeptide Y receptor 0.888 0.763 0.316 1.9e-35
FB|FBgn0035610 Lkr "Leucokinin receptor" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
 Score = 903 (322.9 bits), Expect = 1.5e-90, P = 1.5e-90
 Identities = 169/302 (55%), Positives = 211/302 (69%)

Query:    24 IYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGL 83
             +Y  P  I+ LLS+FYG IS++AV+GN LVIW+VAT+R+M+ VTN +IANLA AD++IGL
Sbjct:    27 LYAAPAEIVALLSIFYGGISIVAVIGNTLVIWVVATTRQMRTVTNMYIANLAFADVIIGL 86

Query:    84 FAIPFQFQAALLQRWNLPNFMCPFCPFVQCXXXXXXXXXXXAIAVDRHRAILNPLSARPS 143
             F IPFQFQAALLQ WNLP FMC FCPFVQ            AIA+DRHRAI+NPL ARP+
Sbjct:    87 FCIPFQFQAALLQSWNLPWFMCSFCPFVQALSVNVSVFTLTAIAIDRHRAIINPLRARPT 146

Query:   144 KLRAKICIFGIWTLSSFLAAPMAIATGVT-MEEEYTDPAGRIHL-KPFCTNIHLSDDTMI 201
             K  +K  I GIW L+   A P AIA  V  + E + +     ++ +PFC N +LSDD + 
Sbjct:   147 KFVSKFIIGGIWMLALLFAVPFAIAFRVEELTERFRENNETYNVTRPFCMNKNLSDDQLQ 206

Query:   202 LYRRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGNAQDSRDATXXXXXXXXXXXXXXX 261
              +R  L  VQY +P  VISFVY +MA+RLWG++APGNAQDSRD T               
Sbjct:   207 SFRYTLVFVQYLVPFCVISFVYIQMAVRLWGTRAPGNAQDSRDITLLKNKKKVIKMLIIV 266

Query:   262 XALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKER 321
               +F +CWLPLQ YN+L    P IN YH+I+IV+FCCDWLAMSNSCYNPFIYGIYN+K +
Sbjct:   267 VIIFGLCWLPLQLYNILYVTIPEINDYHFISIVWFCCDWLAMSNSCYNPFIYGIYNEKFK 326

Query:   322 KK 323
             ++
Sbjct:   327 RE 328
GO:0004983 "neuropeptide Y receptor activity" evidence=ISS
GO:0007217 "tachykinin receptor signaling pathway" evidence=ISS
GO:0004995 "tachykinin receptor activity" evidence=ISS
GO:0016021 "integral to membrane" evidence=ISS
GO:0008188 "neuropeptide receptor activity" evidence=ISS
GO:0007186 "G-protein coupled receptor signaling pathway" evidence=ISS
GO:0042071 "leucokinin receptor activity" evidence=IDA
GO:0016323 "basolateral plasma membrane" evidence=IDA
GO:0004984 "olfactory receptor activity" evidence=IEA
WB|WBGene00006428 tkr-3 [Caenorhabditis elegans (taxid:6239)] Back     alignment and assigned GO terms
FB|FBgn0004622 Takr99D "Tachykinin-like receptor at 99D" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
UNIPROTKB|Q8QFM1 NPY1R "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
FB|FBgn0004842 NepYr "Neuropeptide Y receptor-like" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
UNIPROTKB|Q8QGM3 PPYR1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|O02835 NPY1R "Neuropeptide Y receptor type 1" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-060526-185 tacr1a "tachykinin receptor 1a" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
UNIPROTKB|F1NJ82 TACR3 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-980526-393 npy4r "neuropeptide Y receptor Y4" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

Original result of BLAST against SWISS-PROT

ID ?Name ?Annotated EC number ?Identity ?Query coverage ?Hit coverage ?RBH(Q2H) ?RBH(H2Q) ?
O02835NPY1R_PIGNo assigned EC number0.340.91040.7702yesN/A
O02813NPY1R_CANFANo assigned EC number0.330.91040.7722yesN/A
Q1RMU8NPY1R_BOVINNo assigned EC number0.330.91040.7702yesN/A
Q9WVD0NPY1R_CAVPONo assigned EC number0.33660.91040.7702yesN/A
P21452NK2R_HUMANNo assigned EC number0.32820.91970.7487yesN/A
Q04573NPY1R_MOUSENo assigned EC number0.33660.91040.7722yesN/A
P21555NPY1R_RATNo assigned EC number0.33660.91040.7722yesN/A

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!

Prediction of Functionally Associated Proteins

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against CDD database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query324
pfam00001251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 4e-55
PHA03087335 PHA03087, PHA03087, G protein-coupled chemokine re 8e-22
PHA02638417 PHA02638, PHA02638, CC chemokine receptor-like pro 2e-11
PHA02834323 PHA02834, PHA02834, chemokine receptor-like protei 1e-07
PHA03235 409 PHA03235, PHA03235, DNA packaging protein UL33; Pr 8e-04
>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information 
 Score =  179 bits (457), Expect = 4e-55
 Identities = 71/261 (27%), Positives = 123/261 (47%), Gaps = 12/261 (4%)

Query: 55  WIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPNFMCPFCPFVQCL 114
            ++  +++++  TN F+ NLA+AD++  L   P+     +   W   + +C    F+  +
Sbjct: 1   LVILRTKKLRTPTNIFLLNLAVADLLFLLTLPPWALYYLVGGDWPFGDALCKLVGFLFVV 60

Query: 115 TVTVSVLTLTAIAVDRHRAILNPLSARP--SKLRAKICIFGIWTLSSFLAAPMAIATGVT 172
               S+L LTAI++DR+ AI++PL  R   +  RAK+ I  +W L+  L+ P  + + + 
Sbjct: 61  NGYASILLLTAISIDRYLAIVHPLRYRRIRTPRRAKVLILVVWVLALLLSLPPLLFSWLR 120

Query: 173 MEEEYTDPAGRIHLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWG 232
             EE             C      + T   Y  +  ++ + +PL VI   Y  +   L  
Sbjct: 121 TVEEGNV--------TTCLIDFPEESTKRSYTLLSTLLGFVLPLLVILVCYTLILRTLRK 172

Query: 233 SKAPGNAQDSRDATLMKNKKKVIKMLVIVVALFAICWLPLQTYNVLQGIFPSINSYHYIN 292
               G +Q     +  K ++K  KML++VV +F +CWLP     +L  + P ++ +  + 
Sbjct: 173 RARSGASQARAKRSSSK-ERKAAKMLLVVVVVFVLCWLPYHIVLLLDSLCP-LSIWRLLP 230

Query: 293 IVFFCCDWLAMSNSCYNPFIY 313
                  WLA  NSC NP IY
Sbjct: 231 TALLITLWLAYVNSCLNPIIY 251

This family contains, amongst other G-protein-coupled receptors (GCPRs), members of the opsin family, which have been considered to be typical members of the rhodopsin superfamily. They share several motifs, mainly the seven transmembrane helices, GCPRs of the rhodopsin superfamily. All opsins bind a chromophore, such as 11-cis-retinal. The function of most opsins other than the photoisomerases is split into two steps: light absorption and G-protein activation. Photoisomerases, on the other hand, are not coupled to G-proteins - they are thought to generate and supply the chromophore that is used by visual opsins. Length = 251
>gnl|CDD|222976 PHA03087, PHA03087, G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|165021 PHA02638, PHA02638, CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|165177 PHA02834, PHA02834, chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|223017 PHA03235, PHA03235, DNA packaging protein UL33; Provisional Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

Original result of HHsearch against CDD database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 324
KOG4219|consensus423 100.0
PHA03234338 DNA packaging protein UL33; Provisional 100.0
PHA03235409 DNA packaging protein UL33; Provisional 100.0
PHA02834323 chemokine receptor-like protein; Provisional 100.0
PHA02638417 CC chemokine receptor-like protein; Provisional 100.0
PHA03087335 G protein-coupled chemokine receptor-like protein; 100.0
KOG4220|consensus503 100.0
PF00001257 7tm_1: 7 transmembrane receptor (rhodopsin family) 100.0
KOG2087|consensus363 99.93
PF10320257 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep 99.92
PF10324318 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept 99.89
PF10328274 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept 99.86
PF05296303 TAS2R: Mammalian taste receptor protein (TAS2R); I 99.72
PF10323283 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept 99.71
PF05462303 Dicty_CAR: Slime mold cyclic AMP receptor 99.61
PF10321313 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept 99.56
PF03402265 V1R: Vomeronasal organ pheromone receptor family, 99.38
PF10326307 7TM_GPCR_Str: Serpentine type 7TM GPCR chemorecept 99.1
PF10317292 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept 99.09
PF10292324 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor c 99.06
PF11710201 Git3: G protein-coupled glucose receptor regulatin 99.04
PF02118275 Srg: Srg family chemoreceptor; InterPro: IPR000609 99.04
PF10327303 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept 99.01
PF02101405 Ocular_alb: Ocular albinism type 1 protein; InterP 98.9
PF10319310 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemorecept 98.74
PF10316273 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep 98.7
PF02117328 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemorecept 98.49
PF00002242 7tm_2: 7 transmembrane receptor (Secretin family); 98.48
PF10318302 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemorecept 98.32
PF04789305 DUF621: Protein of unknown function (DUF621); Inte 98.25
PF10322307 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemorecept 98.14
KOG4193|consensus610 98.11
KOG4564|consensus473 97.83
PF01534328 Frizzled: Frizzled/Smoothened family membrane regi 97.75
PF03125365 Sre: C. elegans Sre G protein-coupled chemorecepto 97.65
PF02076283 STE3: Pheromone A receptor; InterPro: IPR001499 G- 97.34
PF02175236 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemorecept 96.36
PF1197076 Git3_C: G protein-coupled glucose receptor regulat 96.31
PF03383153 Serpentine_r_xa: Caenorhabditis serpentine recepto 94.12
PF06681226 DUF1182: Protein of unknown function (DUF1182); In 90.87
PF06454281 DUF1084: Protein of unknown function (DUF1084); In 85.88
KOG4289|consensus2531 81.8
>KOG4219|consensus Back     alignment and domain information 
Probab=100.00  E-value=3.4e-49  Score=317.32  Aligned_cols=300  Identities=41%  Similarity=0.734  Sum_probs=258.6

Q ss_pred             eccccchHHHHHHHHHHHHHHHHHhhhhheeeeeeeecccccchhhHHHHHHHHHHHHHHHhhhhHHHHHHhhccCCCCc
Q psy5192          23 GIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPN  102 (324)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~i~~~~gi~~N~~vl~~i~~~~~~~~~~~~~l~~La~~dll~~~~~~~~~~~~~~~~~~~~~~  102 (324)
                      +.+..+...+.+.++++.++.+++++||.++++++..+|++|+.+|+++.|||+||++.+++..++........+|.+|.
T Consensus        26 ~~f~lp~~~~~~wai~yg~l~~vAv~GN~iVlwIil~hrrMRtvtnyfL~NLAfADl~~s~Fn~~f~f~yal~~~W~~G~  105 (423)
T KOG4219|consen   26 GLFVLPAWQQALWAIAYGLLVFVAVVGNLIVLWIILAHRRMRTVTNYFLVNLAFADLSMSIFNTVFNFQYALHQEWYFGS  105 (423)
T ss_pred             CcccCCHHHHHHHHHHHHHHHHHHHhcCceEEEEEeehhehhhhHHHHHHHHHHHHHHHHHHhhHHHHHHHHHhcccccc
Confidence            35778889999999999999999999999999999999999999999999999999999999999999888889999999


Q ss_pred             cccccchhhhHHHHHHHHHHHHHHHHHHHhHhhccCCcCCCccccceeehhHHHHHHHhhhhhheeeceeeeeeecCCCC
Q psy5192         103 FMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAILNPLSARPSKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPAG  182 (324)
Q Consensus       103 ~~C~~~~~~~~~~~~~s~~~~~~is~dRy~~i~~p~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (324)
                      ..|++..++......+|++++++||+|||.||.+|++.+.+++..+.+++.+|+.+++.+.|..+.........++....
T Consensus       106 f~C~f~nf~~itav~vSVfTlvAiA~DRy~AIi~Pl~~r~s~r~sk~iIllIW~lA~l~a~P~~l~s~v~~~~~~d~~~~  185 (423)
T KOG4219|consen  106 FYCRFVNFFPITAVFVSVFTLVAIAIDRYMAIIHPLQPRPSRRSSKIIILLIWALALLLALPQLLYSSVEELYLYDGESR  185 (423)
T ss_pred             ceeeeccccchhhhhHhHHHHHHHHHHHHHHHhhhcccCCCCcceeehhHHHHHHHHHHhccceeeeeeEEeeccCCcce
Confidence            99999999999999999999999999999999999999999999999999999999999999988877655544321111


Q ss_pred             cc----cccccccccCCCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCCCCccccHHHHhhhhhHHHHH
Q psy5192         183 RI----HLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGNAQDSRDATLMKNKKKVIKML  258 (324)
Q Consensus       183 ~~----~~~~~c~~~~~~~~~~~~~~~~~~~~~~~ip~~i~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (324)
                      ..    .....|... ......+.|.....++.+++|++++...|..|.+++|.++..++.+. ++.++.++++|+.|++
T Consensus       186 ~~~~~~~pe~~~~~~-~~~~~~~~y~~vl~~lqYflPliVl~~~Yt~iav~LW~~~~~gd~~d-~~~~~~kak~K~vkml  263 (423)
T KOG4219|consen  186 VVCVTAWPEHVCPTE-NESLLMQGYNYVLLFLQYFLPLIVLGLAYTVIAVTLWGRRIPGDQQD-RKHEQLKAKKKVVKML  263 (423)
T ss_pred             EEEEEecccccCCcc-hhhhhhcceeeeehhHHHHHHHHHHHHHHHHHHHHHHhccCccchhc-hhhHHHHHHHHHHHHH
Confidence            10    011112110 01111123777888999999999999999999999999986665544 5556678889999999


Q ss_pred             HHHHHHHHHhhhhHHHHHHHhhhccCccchhHHHHHHHHHHHhhhccccccceeeeecCcccccCC
Q psy5192         259 VIVVALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKERKKN  324 (324)
Q Consensus       259 ~~~~~~f~~~~~P~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~npiiy~~~~~~~R~~~  324 (324)
                      ++++..|.+||+|+.++.++....++..+.......+....|+++.|++.||+||++.|++||.+|
T Consensus       264 iiVV~~FaicWlPyh~y~il~~~~~~i~~~k~i~~vyl~~~WLaMSst~yNPiIY~~lN~Rfr~gf  329 (423)
T KOG4219|consen  264 IIVVVIFAICWLPYHIYFILNATNPEINRKKFIQQVYLAIYWLAMSSTCYNPIIYCFLNKRFRGGF  329 (423)
T ss_pred             HHHHHHHHHhccChhHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHhhhccHhhhhhHHHHHHHH
Confidence            999999999999999999998888888888888899999999999999999999999999999764

>PHA03234 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA03235 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA02834 chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA02638 CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA03087 G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>KOG4220|consensus Back     alignment and domain information
>PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG2087|consensus Back     alignment and domain information
>PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) Back     alignment and domain information
>PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF05462 Dicty_CAR: Slime mold cyclic AMP receptor Back     alignment and domain information
>PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] Back     alignment and domain information
>PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10326 7TM_GPCR_Str: Serpentine type 7TM GPCR chemoreceptor Str; InterPro: IPR019428 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10292 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor class ab chemoreceptor; InterPro: IPR019408 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>PF02118 Srg: Srg family chemoreceptor; InterPro: IPR000609 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes Back     alignment and domain information
>PF10319 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemoreceptor Srj; InterPro: IPR019423 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02117 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemoreceptor Sra; InterPro: IPR000344 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF00002 7tm_2: 7 transmembrane receptor (Secretin family); InterPro: IPR000832 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10318 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemoreceptor Srh; InterPro: IPR019422 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity Back     alignment and domain information
>PF10322 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemoreceptor Sru; InterPro: IPR003839 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4193|consensus Back     alignment and domain information
>KOG4564|consensus Back     alignment and domain information
>PF01534 Frizzled: Frizzled/Smoothened family membrane region; InterPro: IPR000539 The frizzled (fz) locus of Drosophila coordinates the cytoskeletons of epidermal cells, producing a parallel array of cuticular hairs and bristles [, ] Back     alignment and domain information
>PF03125 Sre: C Back     alignment and domain information
>PF02076 STE3: Pheromone A receptor; InterPro: IPR001499 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02175 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemoreceptor Srb; InterPro: IPR002184 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF11970 Git3_C: G protein-coupled glucose receptor regulating Gpa2 C-term; InterPro: IPR022596 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>PF03383 Serpentine_r_xa: Caenorhabditis serpentine receptor-like protein, class xa; InterPro: IPR005047 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF06681 DUF1182: Protein of unknown function (DUF1182); InterPro: IPR010601 This family consists of several hypothetical proteins of around 360 residues in length and seems to be specific to Caenorhabditis elegans Back     alignment and domain information
>PF06454 DUF1084: Protein of unknown function (DUF1084); InterPro: IPR009457 This entry consists of several hypothetical plant specific proteins of unknown function Back     alignment and domain information
>KOG4289|consensus Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

Original result of BLAST against Protein Data Bank

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query324
2ks9_A364 Solution Conformation Of Substance P In Water Compl 3e-29
4ea3_B434 Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WI 2e-20
4gbr_A309 N-terminal T4 Lysozyme Fusion Facilitates Crystalli 6e-19
3sn6_R514 Crystal Structure Of The Beta2 Adrenergic Receptor- 5e-18
3kj6_A366 Crystal Structure Of A Methylated Beta2 Adrenergic 5e-18
2r4s_A342 Crystal Structure Of The Human Beta2 Adrenoceptor L 5e-18
2r4r_A365 Crystal Structure Of The Human Beta2 Adrenoceptor L 7e-18
2vt4_A313 Turkey Beta1 Adrenergic Receptor With Stabilising M 8e-18
2y00_B315 Turkey Beta1 Adrenergic Receptor With Stabilising M 4e-17
3p0g_A 501 Structure Of A Nanobody-Stabilized Active State Of 1e-15
2rh1_A 500 High Resolution Crystal Structure Of Human B2-Adren 1e-15
3pds_A 458 Irreversible Agonist-Beta2 Adrenoceptor Complex Len 2e-15
3d4s_A 490 Cholesterol Bound Form Of Human Beta2 Adrenergic Re 3e-15
3vg9_A326 Crystal Structure Of Human Adenosine A2a Receptor W 5e-14
3pwh_A329 Thermostabilised Adenosine A2a Receptor Length = 32 8e-14
2ydo_A325 Thermostabilised Human A2a Receptor With Adenosine 2e-13
4djh_A 480 Structure Of The Human Kappa Opioid Receptor In Com 1e-11
3rze_A 452 Structure Of The Human Histamine H1 Receptor In Com 2e-10
4daj_A 479 Structure Of The M3 Muscarinic Acetylcholine Recept 2e-10
3eml_A 488 The 2.6 A Crystal Structure Of A Human A2a Adenosin 4e-10
4eiy_A 447 Crystal Structure Of The Chimeric Protein Of A2aar- 5e-10
4dkl_A 464 Crystal Structure Of The Mu-Opioid Receptor Bound T 8e-10
4ej4_A 461 Structure Of The Delta Opioid Receptor Bound To Nal 2e-08
3uon_A 467 Structure Of The Human M2 Muscarinic Acetylcholine 2e-08
3odu_A 502 The 2.5 A Structure Of The Cxcr4 Chemokine Receptor 5e-08
3oe0_A 499 Crystal Structure Of The Cxcr4 Chemokine Receptor I 5e-08
3oe6_A 508 Crystal Structure Of The Cxcr4 Chemokine Receptor I 5e-08
3pbl_A 481 Structure Of The Human Dopamine D3 Receptor In Comp 1e-06
3oax_A349 Crystal Structure Of Bovine Rhodopsin With Beta-Ion 2e-06
1jfp_A348 Structure Of Bovine Rhodopsin (Dark Adapted) Length 2e-06
2x72_A349 Crystal Structure Of The Constitutively Active E113 4e-06
2j4y_A349 Crystal Structure Of A Rhodopsin Stabilizing Mutant 4e-06
3c9m_A348 Structure Of A Mutant Bovine Rhodopsin In Hexagonal 4e-06
4a4m_A349 Crystal Structure Of The Light-Activated Constituti 4e-06
>pdb|2KS9|A Chain A, Solution Conformation Of Substance P In Water Complexed With Nk1r Length = 364 Back     alignment and structure 
Iteration: 1

 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 95/301 (31%), Positives = 136/301 (45%), Gaps = 22/301 (7%)
Query: 28  PTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIP 87
           P   I+L +  Y  I V +VVGN +V+WI+   +RM+ VTN F+ NLA A+  +  F   
Sbjct: 28  PAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTV 87
Query: 88  FQFQAALLQRWNLPNFMCPFCPFVQCXXXXXXXXXXXAIAVDRHRAILNPLSARPSKLRA 147
             F  A+   W    F C F  F              A+A DR+ AI++PL  R S    
Sbjct: 88  VNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQPRLSATAT 147
Query: 148 KICIFGIWTLSSFLAAPMA-IATGVTMEE------EYTDPAGRIHLKPFCTNIHLSDDTM 200
           K+ I  IW L+  LA P    +T  TM        E+ +   +I+ K             
Sbjct: 148 KVVICVIWVLALLLAFPQGYYSTTETMPSRVVCMIEWPEHPNKIYEK------------- 194
Query: 201 ILYRRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGNAQDSRDATXXXXXXXXXXXXXX 260
            +Y   + V+ Y +PL VI + Y  + + LW S+ PG++ D R                 
Sbjct: 195 -VYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSD-RYHEQVSAKRKVVKMMIV 252
Query: 261 XXALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKE 320
               FAICWLP   + +L  I P +    +I  V+    WLAMS++ YNP IY   ND+ 
Sbjct: 253 VVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRF 312
Query: 321 R 321
           R
Sbjct: 313 R 313
>pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE Mimetic Length = 434 Back     alignment and structure
>pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 Back     alignment and structure
>pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 Back     alignment and structure
>pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 Back     alignment and structure
>pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 Back     alignment and structure
>pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 Back     alignment and structure
>pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 Back     alignment and structure
>pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 Back     alignment and structure
>pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 Back     alignment and structure
>pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 Back     alignment and structure
>pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 Back     alignment and structure
>pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 Back     alignment and structure
>pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 Back     alignment and structure
>pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 Back     alignment and structure
>pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 Back     alignment and structure
>pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 Back     alignment and structure
>pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 Back     alignment and structure
>pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 Back     alignment and structure
>pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 Back     alignment and structure
>pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 Back     alignment and structure
>pdb|4DKL|A Chain A, Crystal Structure Of The Mu-Opioid Receptor Bound To A Morphinan Antagonist Length = 464 Back     alignment and structure
>pdb|4EJ4|A Chain A, Structure Of The Delta Opioid Receptor Bound To Naltrindole Length = 461 Back     alignment and structure
>pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 Back     alignment and structure
>pdb|3ODU|A Chain A, The 2.5 A Structure Of The Cxcr4 Chemokine Receptor In Complex With Small Molecule Antagonist It1t Length = 502 Back     alignment and structure
>pdb|3OE0|A Chain A, Crystal Structure Of The Cxcr4 Chemokine Receptor In Complex With A Cyclic Peptide Antagonist Cvx15 Length = 499 Back     alignment and structure
>pdb|3OE6|A Chain A, Crystal Structure Of The Cxcr4 Chemokine Receptor In Complex With A Small Molecule Antagonist It1t In I222 Spacegroup Length = 508 Back     alignment and structure
>pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 Back     alignment and structure
>pdb|3OAX|A Chain A, Crystal Structure Of Bovine Rhodopsin With Beta-Ionone Length = 349 Back     alignment and structure
>pdb|1JFP|A Chain A, Structure Of Bovine Rhodopsin (Dark Adapted) Length = 348 Back     alignment and structure
>pdb|2X72|A Chain A, Crystal Structure Of The Constitutively Active E113q,N2c, D282c Rhodopsin Mutant With Bound Galphact Peptide Length = 349 Back     alignment and structure
>pdb|2J4Y|A Chain A, Crystal Structure Of A Rhodopsin Stabilizing Mutant Expressed In Mammalian Cells Length = 349 Back     alignment and structure
>pdb|3C9M|A Chain A, Structure Of A Mutant Bovine Rhodopsin In Hexagonal Crystal Form Length = 348 Back     alignment and structure
>pdb|4A4M|A Chain A, Crystal Structure Of The Light-Activated Constitutively Active N2c,M257y,D282c Rhodopsin Mutant In Complex With A Peptide Resembling The C-Terminus Of The Galpha-Protein Subunit (Gact) Length = 349 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

Original result of RPS-BLAST against PDB70 database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query324
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 1e-112
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 1e-87
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 7e-66
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 5e-51
2z73_A 448 Rhodopsin; visual pigment, GQ-type, G-protein coup 2e-49
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 2e-48
4dkl_A 464 MU-type opioid receptor, lysozyme chimera; G-prote 3e-40
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 3e-15
4eiy_A 447 Adenosine receptor A2A/soluble cytochrome B562 CH; 1e-37
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 9e-10
3eml_A 488 Human adenosine A2A receptor/T4 lysozyme chimera; 5e-37
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 7e-12
3odu_A 502 C-X-C chemokine receptor type 4, lysozyme chimera; 9e-37
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 4e-09
3uon_A 467 Human M2 muscarinic acetylcholine, receptor T4 LY 1e-34
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 2e-08
3rze_A 452 Histamine H1 receptor, lysozyme chimera; structura 3e-34
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 9e-09
2rh1_A 500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 1e-33
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 2e-08
3pbl_A 481 D(3) dopamine receptor, lysozyme chimera; structur 6e-32
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 4e-09
3v2y_A 520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 2e-28
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 3e-10
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 Back     alignment and structure
 Score =  328 bits (842), Expect = e-112
 Identities = 104/326 (31%), Positives = 155/326 (47%), Gaps = 16/326 (4%)

Query: 1   METQNLKGYKSDETVSITEKYLGIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATS 60
           M+            +S        +  P   I+L +  Y  I V +VVGN +V+WI+   
Sbjct: 1   MDNVLPVDSDLSPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAH 60

Query: 61  RRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPNFMCPFCPFVQCLTVTVSV 120
           +RM+ VTN F+ NLA A+  +  F     F  A+   W    F C F  F     V  S+
Sbjct: 61  KRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASI 120

Query: 121 LTLTAIAVDRHRAILNPLSARPSKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDP 180
            ++TA+A DR+ AI++PL  R S    K+ I  IW L+  LA P    +           
Sbjct: 121 YSMTAVAFDRYMAIIHPLQPRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPSRV-- 178

Query: 181 AGRIHLKPFCTNIHLSDDTMILYRRV----LAVVQYAIPLSVISFVYARMALRLWGSKAP 236
                    C  I   +    +Y +V    + V+ Y +PL VI + Y  + + LW S+ P
Sbjct: 179 --------VCM-IEWPEHPNKIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIP 229

Query: 237 GNAQDSRDATLMKNKKKVIKMLVIVVALFAICWLPLQTYNVLQGIFPSINSYHYINIVFF 296
           G++ D R    +  K+KV+KM+++VV  FAICWLP   + +L  I P +    +I  V+ 
Sbjct: 230 GDSSD-RYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYL 288

Query: 297 CCDWLAMSNSCYNPFIYGIYNDKERK 322
              WLAMS++ YNP IY   ND+ R 
Sbjct: 289 AIMWLAMSSTMYNPIIYCCLNDRFRL 314
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure

Structure Templates Detected by HHsearch ?

Original result of HHsearch against PDB70 database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query324
4grv_A510 Neurotensin receptor type 1, lysozyme chimera; G-p 100.0
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 100.0
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 100.0
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 100.0
3vw7_A484 Proteinase-activated receptor 1, lysozyme; high re 100.0
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 100.0
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 100.0
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 100.0
2lnl_A296 C-X-C chemokine receptor type 1; G protein coupled 100.0
2z73_A 448 Rhodopsin; visual pigment, GQ-type, G-protein coup 100.0
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 100.0
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 100.0
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 100.0
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 100.0
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 100.0
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 100.0
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 100.0
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 100.0
1hll_A32 Alpha-2A adrenergic receptor; helix-linker-helix, 98.44
2koe_A40 Human cannabinoid receptor 1 - helix 7/8 peptide; 98.22
2ki9_A33 Cannabinoid receptor 2; GPCR, G-protein coupled re 97.79
2lot_A64 Apelin receptor; membrane protein; NMR {Homo sapie 95.95
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} Back     alignment and structure
Probab=100.00  E-value=3.8e-48  Score=344.93  Aligned_cols=293  Identities=22%  Similarity=0.358  Sum_probs=228.9

Q ss_pred             cchHHHHHHHHHHHHHHHHHhhhhheeeeeeeecccc---cchhhHHHHHHHHHHHHHHHhhhhHHHHHHhh--ccCCCC
Q psy5192          27 VPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRM---QNVTNCFIANLALADIVIGLFAIPFQFQAALL--QRWNLP  101 (324)
Q Consensus        27 ~~~~~~~~~~~~~~i~~~~gi~~N~~vl~~i~~~~~~---~~~~~~~l~~La~~dll~~~~~~~~~~~~~~~--~~~~~~  101 (324)
                      .+....++..+++.+++++|++||+++++++.++|++   ++++|+|++|||++|++.+++.+|+.+.....  +.|.++
T Consensus        27 ~~~~~~v~~~~~~~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~~~~~~~w~~g  106 (510)
T 4grv_A           27 TDIYSKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIWVHHPWAFG  106 (510)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCCSSCSSH
T ss_pred             hhHHHHHHHHHHHHHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCEEhh
Confidence            3445677888899999999999999999999887654   47889999999999999999999988877654  568999


Q ss_pred             ccccccchhhhHHHHHHHHHHHHHHHHHHHhHhhccCCcCC--CccccceeehhHHHHHHHhhhhhheeeceeeeeeecC
Q psy5192         102 NFMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAILNPLSARP--SKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTD  179 (324)
Q Consensus       102 ~~~C~~~~~~~~~~~~~s~~~~~~is~dRy~~i~~p~~~~~--~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~  179 (324)
                      +..|++..++..++..+|++++++||+|||+||++|++|+.  +++++..+++++|++++++++|+++.++.........
T Consensus       107 ~~~C~~~~~~~~~~~~~S~~~l~~is~dRy~ai~~P~~~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~~~  186 (510)
T 4grv_A          107 DAGCRGYYFLRDACTYATALNVASLSVARYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSADGT  186 (510)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCCCCCCCSCCHHHHHHHHHHHHHHHTTHHHHEEEEECSSSSC
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHheEEEeccccccccccccccceeehHHHHHHHHHHHHHHHhhcccccccCCC
Confidence            99999999999999999999999999999999999998875  8889999999999999999999988776543322111


Q ss_pred             CCCcccccccccccCCCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCC---------------------
Q psy5192         180 PAGRIHLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGN---------------------  238 (324)
Q Consensus       180 ~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~ip~~i~~~~~~~i~~~~~~~~~~~~---------------------  238 (324)
                      .    .....|.. ..+......|..+..++.+++|+++++++|.+|+++++++.+...                     
T Consensus       187 ~----~~~~~c~~-~~~~~~~~~~~~~~~~~~f~iP~~ii~~~Y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (510)
T 4grv_A          187 H----PGGLVCTP-IVDTATVKVVIQVNTFMSFLFPMLVISILNTVIANKLTVMVNIFEMLRIDEGLRLKIYKDTEGYYT  261 (510)
T ss_dssp             C----GGGEEEEE-CSCHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHTSCTHHHHHHHHTCCEEEEEECTTSCEE
T ss_pred             C----CCcccccc-ccccchhhhhhhhhhhHHHhhhHHHHHHHHHHHHHHHHHHhhhhhhhccccccccccccccccccc
Confidence            1    11223543 234455566777777888999999999999999999986432100                     


Q ss_pred             --------------------------------------------------------------------------------
Q psy5192         239 --------------------------------------------------------------------------------  238 (324)
Q Consensus       239 --------------------------------------------------------------------------------  238 (324)
                                                                                                      
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  341 (510)
T 4grv_A          262 IGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQM  341 (510)
T ss_dssp             EETTEECCCSSSHHHHHHSCCC---CCCTTBCCHHHHHHHHHHHHHHHHHHHHHCTTTHHHHHHSCSHHHHHHHHHHHHH
T ss_pred             cccccccCCCCCCCccccccCcCCCCCCCCcccCCccccccCCCCcccccccccCCCCCCCcCccccccccccCCccccC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------CCccccHHHHhhhhhHHHHHHHHHHHHHHh
Q psy5192         239 --------------------------------------------------AQDSRDATLMKNKKKVIKMLVIVVALFAIC  268 (324)
Q Consensus       239 --------------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~  268 (324)
                                                                        ....+.++..++|+|++|++++++++|++|
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~erk~~k~L~iVv~~F~iC  421 (510)
T 4grv_A          342 GETGVAGFTNSLRMLNNKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYGSGSVQALRHGVLVARAVVIAFVVC  421 (510)
T ss_dssp             HHHHHTTCHHHHHHHTTTCHHHHHHHHHSSCSCCSSHHHHHHHHHHHHHSSSGGGTTSTTTHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCccccccccCCCcccccccccccccccCCccccccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence                                                              000000011245789999999999999999


Q ss_pred             hhhHHHHHHHhhhccCccc----hhHHHHHHHHHHHhhhccccccceeeeecCcccccCC
Q psy5192         269 WLPLQTYNVLQGIFPSINS----YHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKERKKN  324 (324)
Q Consensus       269 ~~P~~i~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~~~~npiiy~~~~~~~R~~~  324 (324)
                      |+|+++..++..+.+....    ......+..++.+|+++||++||+||+++|++|||+|
T Consensus       422 WlPf~i~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~L~Y~NS~iNPiIY~~~n~~FR~aF  481 (510)
T 4grv_A          422 WLPYHVRRLMFCYISDEQWTTFLFDFYHYFYMLTNALAYASSAINPILYNLVSANFRQVF  481 (510)
T ss_dssp             HHHHHHHHHHHHTTTTTCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCC-
T ss_pred             HHHHHHHHHHHHHcCcccCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHH
Confidence            9999999888766543322    1233456677889999999999999999999999986
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Back     alignment and structure
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Back     alignment and structure
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* Back     alignment and structure
>1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Back     alignment and structure
>2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} Back     alignment and structure
>2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} Back     alignment and structure
>2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 324
d1u19a_348 f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 4e-33
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 Back     information, alignment and structure

class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  123 bits (308), Expect = 4e-33
 Identities = 64/299 (21%), Positives = 120/299 (40%), Gaps = 14/299 (4%)

Query: 25  YKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLF 84
           Y        +L+ +   + +L    NFL +++    ++++   N  + NLA+AD+ +   
Sbjct: 30  YLAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFG 89

Query: 85  AIPFQFQAALLQRWNLPNFMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAILNPLSARP-S 143
                   +L   +      C    F   L   +++ +L  +A++R+  +  P+S     
Sbjct: 90  GFTTTLYTSLHGYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRFG 149

Query: 144 KLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPAGRIHLKPFCTNIHLSDDTMILY 203
           +  A + +   W ++   AAP  +     + E      G  +  P     + S      +
Sbjct: 150 ENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNES------F 203

Query: 204 RRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGNAQDSRDATLMKNKKKVIKMLVIVVA 263
              + VV + IPL VI F Y ++   +        AQ    AT  K +K+V +M++I+V 
Sbjct: 204 VIYMFVVHFIIPLIVIFFCYGQLVFTVK----EAAAQQQESATTQKAEKEVTRMVIIMVI 259

Query: 264 LFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKERK 322
            F ICWLP                  +  I      + A +++ YNP IY + N + R 
Sbjct: 260 AFLICWLPYAGVAFYIFTHQ---GSDFGPIFMTIPAFFAKTSAVYNPVIYIMMNKQFRN 315

Homologous Domains Detected by HHsearch ?

Original result of HHsearch against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query324
d1u19a_348 Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} 100.0
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.9e-41  Score=282.67  Aligned_cols=289  Identities=21%  Similarity=0.301  Sum_probs=230.2

Q ss_pred             eccccchHHHHHHHHHHHHHHHHHhhhhheeeeeeeecccccchhhHHHHHHHHHHHHHHHhhhhHHHHHHhhccCCCCc
Q psy5192          23 GIYKVPTSIIILLSVFYGTISVLAVVGNFLVIWIVATSRRMQNVTNCFIANLALADIVIGLFAIPFQFQAALLQRWNLPN  102 (324)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~i~~~~gi~~N~~vl~~i~~~~~~~~~~~~~l~~La~~dll~~~~~~~~~~~~~~~~~~~~~~  102 (324)
                      ..+..++....++++++.+++++|++||+++++++.++|++|++.|+++.|||++|++.++...|..+.....+.|..+.
T Consensus        28 ~~~~~~~~~~~~~~~~~~ii~v~gi~gN~lvi~vi~~~k~lr~~~~~~l~nLaiaDll~~~~~~~~~~~~~~~~~~~~~~  107 (348)
T d1u19a_          28 QYYLAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGP  107 (348)
T ss_dssp             CTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHTSCTTHH
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHHHHHHHeehhhhccCCCCCHhHHHHHHHHHHHHHHHHHHHHHhhhhhccCccccCc
Confidence            44445555677888999999999999999999999999999999999999999999999999999888888888888889


Q ss_pred             cccccchhhhHHHHHHHHHHHHHHHHHHHhHhhccCCcCC-CccccceeehhHHHHHHHhhhhhheeeceeeeeeecCCC
Q psy5192         103 FMCPFCPFVQCLTVTVSVLTLTAIAVDRHRAILNPLSARP-SKLRAKICIFGIWTLSSFLAAPMAIATGVTMEEEYTDPA  181 (324)
Q Consensus       103 ~~C~~~~~~~~~~~~~s~~~~~~is~dRy~~i~~p~~~~~-~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (324)
                      ..|+...+....+..++.++++++++|||.+|++|++++. ++++.......+|..+.+...|+.+.............+
T Consensus       108 ~~c~~~~~~~~~~~~~s~~~l~~is~~R~~~i~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (348)
T d1u19a_         108 TGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRFGENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGMQCSC  187 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTCCSSSCCCCHHHHHHHHHHHHHHHHHHHSGGGTTSSCCEEETTTTEE
T ss_pred             hhhhhhhhccccceeeecchhhhhhcccceeeeccccccccccccccccceeeehhhhheecccccccceeccCCccccc
Confidence            9999999999999999999999999999999999998876 666777777788989988888887765544333221110


Q ss_pred             CcccccccccccCCCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCCCCccccHHHHhhhhhHHHHHHHH
Q psy5192         182 GRIHLKPFCTNIHLSDDTMILYRRVLAVVQYAIPLSVISFVYARMALRLWGSKAPGNAQDSRDATLMKNKKKVIKMLVIV  261 (324)
Q Consensus       182 ~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~ip~~i~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (324)
                            ..+............+......+..++|.+++.++|.++.+++++++++.+..    .++.++++|.+|+++.+
T Consensus       188 ------~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~i~~~~y~~i~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~i  257 (348)
T d1u19a_         188 ------GIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTVKEAAAQQQES----ATTQKAEKEVTRMVIIM  257 (348)
T ss_dssp             ------ECCCSCCCGGGTHHHHHHHHHHHTTHHHHHHHHHHHTTTTTSSCSCCCSSCSS----SHHHHHHHHHHHHHHHH
T ss_pred             ------ccccccccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccccchh----hhhHHHHhhHhheEEEe
Confidence                  00111122334455666677778888999999999999988887776554332    33446689999999999


Q ss_pred             HHHHHHhhhhHHHHHHHhhhccCccchhHHHHHHHHHHHhhhccccccceeeeecCcccccCC
Q psy5192         262 VALFAICWLPLQTYNVLQGIFPSINSYHYINIVFFCCDWLAMSNSCYNPFIYGIYNDKERKKN  324 (324)
Q Consensus       262 ~~~f~~~~~P~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~npiiy~~~~~~~R~~~  324 (324)
                      +++|++||+|+.+..++....+.....   .....+..+++.+|+++||+||++++++|||++
T Consensus       258 ~~~f~~~~~P~~i~~~~~~~~~~~~~~---~~~~~~~~~l~~~ns~iNPiIY~~~~~~fR~~~  317 (348)
T d1u19a_         258 VIAFLICWLPYAGVAFYIFTHQGSDFG---PIFMTIPAFFAKTSAVYNPVIYIMMNKQFRNCM  317 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTTSCCC---HHHHHHHHHHGGGGGTHHHHHHHHTCHHHHHHH
T ss_pred             ehHHHHHhhHHHhhhheeeccCCcccc---HHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHH
Confidence            999999999999888776554433322   234566778999999999999999999999863